Microwave ablation of multifocal primary liver cancer guided by real-time 3.0T MRI

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68(2):723–750. doi: 10.1002/hep.29913.
   PubMed Web of Science ®Google Scholar
• Saito N, Tanaka T, Nishiohuku H, et al. Transarterial-chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function. Hepatol Res. 2020;50(10):1176–1185. doi: 10.1111/hepr.13550.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58(1):89–97. doi: 10.1016/j.jhep.2012.09.020.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699. doi: 10.1056/NEJM199603143341104.
   PubMed Web of Science ®Google Scholar
• Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a RCT. J Hepatol. 2014;61(1):82–88. doi: 10.1016/j.jhep.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Suwa K, Seki T, Aoi K, et al. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis. Abdom Radiol. 2021;46(8):3790–3797. doi: 10.1007/s00261-021-03008-9.
   PubMed Web of Science ®Google Scholar
• Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J Gastroenterol. 2014;20(15):4160–4166. doi: 10.3748/wjg.v20.i15.4160.
   PubMed Web of Science ®Google Scholar
• Wu CH, Liang PC, Su TH, et al. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma. Hepatol Int. 2021;15(5):1247–1257. doi: 10.1007/s12072-021-10236-0.
   PubMed Web of Science ®Google Scholar
• Chen J, Lin Z, Lin Q, et al. Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy. Int J Hyperthermia. 2020;37(1):192–201. doi: 10.1080/02656736.2020.1728397.
   PubMed Web of Science ®Google Scholar
• Lin Z, Chen J, Yan Y, et al. Microwave ablation of hepatic malignant tumors using 1.5T MRI guidance and monitoring: feasibility and preliminary clinical experience. Int J Hyperthermia. 2019;36(1):1215–1221. doi: 10.1080/02656736.2019.1690166.
   Web of Science ®Google Scholar
• Lin XC, Yan Y, Lin L, et al. Magnetic resonance-guided thermal ablation for small liver malignant tumor located on segment II or IVa abutting the heart: a retrospective cohort study. Int J Hyperthermia. 2021;38(1):1359–1365. doi: 10.1080/02656736.2021.1976851.
   PubMed Web of Science ®Google Scholar
• Cong WM, Bu H, Chen J, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016;22(42):9279–9287. doi: 10.3748/wjg.v22.i42.9279.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720. doi: 10.1159/000509424.
   PubMed Web of Science ®Google Scholar
• Vollmer I, Páez-Carpio A, Sánchez-Lorente D, et al. Preoperative localization of lung nodules: a comparative analysis of hookwire and radio-guided procedures. J Thorac Dis. 2022;14(11):4329–4340. doi: 10.21037/jtd-22-552.
   PubMed Web of Science ®Google Scholar
• Khankan AA, Murakami T, Onishi H, et al. Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging. 2008;27(3):546–551. doi: 10.1002/jmri.21050.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Lencioni R. mRECIST for HCC: performance and novel refinements. J Hepatol. 2020;72(2):288–306. doi: 10.1016/j.jhep.2019.09.026.
   PubMed Web of Science ®Google Scholar
• Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
   PubMed Web of Science ®Google Scholar
• Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2008;12(1):192–198. doi: 10.1007/s11605-007-0392-8.
   PubMed Web of Science ®Google Scholar
• Chen QF, Li W, Yu SC, et al. Consensus of minimally invasive and multidisciplinary comprehensive treatment for hepatocellular carcinoma – 2020 Guangzhou recommendations. Front Oncol. 2021;11:621834. doi: 10.3389/fonc.2021.621834.
   PubMed Web of Science ®Google Scholar
• Darweesh SK, Gad AA. Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: efficacy, safety, and survival. Turk J Gastroenterol. 2019;30(5):445–453. doi: 10.5152/tjg.2019.17191.
   PubMed Web of Science ®Google Scholar
• Ding J, Jing X, Wang Y, et al. Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clin Radiol. 2016;71(12):1270–1276. doi: 10.1016/j.crad.2016.07.002.
   PubMed Web of Science ®Google Scholar
• Kong S, Yue X, Kong S, et al. Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation. Oncol Lett. 2018;16(2):2434–2438. doi: 10.3892/ol.2018.8898.
   PubMed Web of Science ®Google Scholar
• Nan Y, Xu X, Gao Y, et al. Consensus on the secondary prevention of primary liver cancer. Hepatol Int. 2021;15(6):1289–1300. doi: 10.1007/s12072-021-10259-7.
   PubMed Web of Science ®Google Scholar
• Thompson SM, Gorny KR, Koepsel EMK, et al. Body interventional MRI for diagnostic and interventional radiologists: current practice and future prospects. Radiographics. 2021;41(6):1785–1801. doi: 10.1148/rg.2021210040.
   PubMed Web of Science ®Google Scholar
• Morana G, Salviato E, Guarise A. Contrast agents for hepatic MRI. Cancer Imaging. 2007;7(Special issue A):S24–S27. doi: 10.1102/1470-7330.2007.9001.
   PubMedGoogle Scholar
• Feinberg DA, Giese D, Bongers DA, et al. Hybrid ultrasound MRI for improved cardiac imaging and real-time respiration control. Magn Reson Med. 2010;63(2):290–296. doi: 10.1002/mrm.22250.
   PubMed Web of Science ®Google Scholar
• Wei J, Chen P, Liu B, et al. A multienergy computed tomography method without image segmentation or prior knowledge of X-ray spectra or materials. Heliyon. 2022;8(11):e11584. doi: 10.1016/j.heliyon.2022.e11584.
   PubMed Web of Science ®Google Scholar
• Weiss J, Winkelmann MT, Gohla G, et al. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperthermia. 2020;37(1):349–355. doi: 10.1080/02656736.2020.1750713.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhao G, Dong H. Effect of radiofrequency ablation with interventional therapy of hepatic artery on the recurrence of primary liver cancer and the analysis of influencing factors. J Oncol. 2021;2021:3392433. doi: 10.1155/2021/3392433.
   PubMed Web of Science ®Google Scholar
• Clasen S, Rempp H, Hoffmann R, et al. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111–116. doi: 10.1016/j.ejrad.2013.09.018.
   PubMed Web of Science ®Google Scholar
• Peng Y, Cui D, Li W, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: a pilot clinical study. J Cancer Res Ther. 2021;17(3):764–770. doi: 10.4103/jcrt.JCRT_1851_20.
   PubMed Web of Science ®Google Scholar
• Yu Z, Li G, Yuan N, et al. Comparison of ultrasound guided versus CT guided radiofrequency ablation on liver function, serum PIVKA-II, AFP levels and recurrence in patients with primary hepatocellular carcinoma. Am J Transl Res. 2021;13(6):6881–6888.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6):863–869. doi: 10.1080/02656736.2017.1370728.
   PubMed Web of Science ®Google Scholar